Search Results
Apr 23, 2026, 15:50 ET Open Letter to the 45th and 47th President of the United States, Donald J. Trump on Maine and State Leaders Restricting America's Energy Future
multimedia:https://www.prnewswire.com/news-releases/open-letter-to-the-45th-and-47th-president-of-the-united-states-donald-j-trump-on-maine-and-state-leaders-restricting-americas-energy-future-302752251.htmlSOURCE
More news about: NeutronX Corporation and NextNRG, Inc.
Apr 23, 2026, 13:57 ET Peoples Ltd. Announces First Quarter Results
WYALUSING, Pa., April 23, 2026 /PRNewswire/ -- Peoples Ltd. (OTC: PPLL) Anthony J. Gabello, President and Chief Executive Officer of Peoples Ltd., holding company for PS Bank, has announced results for the first quarter 2026.
More news about: Peoples Ltd.
Apr 23, 2026, 11:38 ET Alan J. Patricof, Venture Capital Pioneer and Champion of Aging and Longevity, Joins CaringKind's Board of Directors
our board."About Alan J. PatricofAlan J. Patricof is the Co-Founder and
More news about: CaringKind
Apr 23, 2026, 11:00 ET Neurava Awarded $4 Million NIH Blueprint Optimizer Award to Develop SUDEP Risk Stratification Algorithm
critical next step for the epilepsy field and for patients," said George Richerson, MD, PhD, Professor and Chair, Department of Neurology and the Roy J Carver Chair in Neuroscience, University of Iowa. "This effort has the potential to bring together decades of knowledge on seizure, cardiac, and respiratory
More news about: Neurava Inc.
Apr 23, 2026, 10:45 ET Securities Lending Market Volume Expected to Reach $21,499.9 Million by 2034 at CAGR of 5.7% | Allied Market Research
future settlement Asian market infrastructure for the securities lending community.April 2023 Strategic Alliance between JPMorgan & Sha regain: J. P. Morgan, a global leader in financial services, partnered with fintech firm Sha regain to expand its agency securities lending capabilities
More news about: Allied Market Research
Apr 23, 2026, 10:10 ET 臨床研究顯示 Promentum® Recover 低劑量運動後恢復方案的功效
研究人員指出，劇烈運動與其後出現的睡眠干擾之間存在關聯，而該等干擾會令恢復過程更為複雜，並延長恢復時間。研究作者亦指出，研究中所採用的 300 毫克小劑量配方，其所含薑黃及石榴萃取物的劑量較一般用於達致恢復功效的水平「顯著較低」；同時，這些萃取物與果糖硼酸鈣之間的潛在協同作用值得進一步研究，亦不能排除其存在。FutureCeuticals 研發副總裁兼總法律顧問 J. Randal Wexler 表示：「本研究是首次就我們的旗艦成分果糖硼酸鈣於運動恢復領域的應用發表臨床研究，並將我們針對該專利礦物複合物所累積的廣泛研究拓展至運動營養市場，同時帶來新增功效。 這些恢復功效與我們在關節健康及活動能力領域長期建立的臨床與商業成果相輔相成。」關於
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:51 ET 발표된 임상시험, 운동 후 회복을 위한 저용량 솔루션으로서 프로멘텀® 리커버의 효능 입증
회복 효능을 달성하기 위해 일반적으로 사용되는 것보다 '현저히 낮은' 용량의 강황과 석류 추출물이 포함되었다고 언급했고, 칼슘 프룩토보레이트와 이러한 추출물들의 잠재적 시너지는 추가 임상시험을 진행할 가치가 있으며 배제할 수 없다고 밝혔다.퓨처슈티컬스의 J. 랜달 웩슬러(J. Randal Wexler) 연구개발 및 법무 자문위원은 "이 임상시험은 운동 회복의 맥락에서 퓨처슈티컬스의 대표 성분인 칼슘 프룩토보레이트에 대한 최초의 발표된 임상 조사로, 특허받은 미네랄 복합체에 대한 당사의 광범위한 기존 임상시험을 새로 추가된
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:37 ET Veröffentlichte klinische Studie veranschaulicht Vorteile von Promentum® Recover als niedrig dosierte Lösung zur Erholung nach dem Sport
unsere umfangreichen Forschungsergebnisse über den patentierten Mineralstoffkomplex auf den Sporternährungsmarkt und bringt neue Vorteile mit sich", sagte J. Randal Wexler, Vice President of R&D and General Counsel bei FutureCeuticals. „Diese Vorteile für die Genesung sind eine natürliche Ergänzung zu
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:36 ET Une étude clinique publiée illustre les avantages de Promentum® Recover en tant que solution à faible dose pour la récupération après l'exercice.
notre large éventail de recherches existantes sur le complexe minéral breveté au marché de la nutrition sportive avec de nouveaux avantages », a déclaré J. Randal Wexler, vice-président de la R&D et avocat général de FutureCeuticals. « Ces avantages en termes de récupération sont un complément naturel
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:30 ET El estudio clínico publicado ilustra los beneficios de Promentum® Recover como solución de dosis baja para la recuperación posterior al ejercicio
de investigación existente sobre el complejo mineral patentado en el mercado de la nutrición deportiva con beneficios recientemente agregados", dijo J. Randal Wexler, vicepresidente de I + D y asesor general de FutureCeuticals. "Estos beneficios de recuperación son un complemento natural de nuestra
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:27 ET Un estudio clínico publicado ilustra los beneficios de Promentum® Recover
ampliando así nuestra extensa investigación sobre el complejo mineral patentado al mercado de la nutrición deportiva con nuevos beneficios", declaró J. Randal Wexler, vicepresidente de I+D y asesor jurídico general de FutureCeuticals. "Estos beneficios para la recuperación son un complemento natural
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:23 ET Estudo clínico publicado ilustra os benefícios do Promentum® Recover como solução de baixa dose para recuperação pós-exercício
nosso amplo corpo de pesquisas existentes sobre o complexo mineral patenteado no mercado de nutrição esportiva com benefícios recém-adicionados", disse J. Randal Wexler, Vice-Presidente de P&D e Conselheiro Geral da FutureCeuticals. "Esses benefícios de recuperação são um complemento natural à
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 09:07 ET Bright Uro Launches Glean® Patient Registry to Create Urodynamic Intelligence™
www.GleanUDS.com.References:Stewart WF, et al. World J Urol. 2003;20:327–336.NIDDK, NIH. Urologic Diseases in America Annual Data Report. April 26, 2024.Dorsher PT, et al. Adv Urol. 2012;2012:816274.Lee UJ, et al. J Urol. 2021;205(6):1718–1724.
More news about: Bright Uro
Apr 23, 2026, 09:00 ET MARC JACOBS DEBUTS "THE SCENE" STARRING RACHEL SENNOTT
brand.Designed to be noticed, The Scene Bag is offered in three sizes and colorways. Featuring signature hardware, a sculptural silhouette, and the J Marc logo, the bag is built to turn heads and command presence. The collection also introduces new colorways of
More news about: Marc Jacobs
Apr 23, 2026, 09:00 ET West Coast Community Bancorp Announces Annual Shareholder Voting Results
57.00Kurt J. Gollnick6,464,284
More news about: West Coast Community Bancorp
Apr 23, 2026, 08:57 ET Trucordia Adds Shelley Rathsam as Vice President on M&A Team
Shelley Rathsam has joined the company as Vice President on its Mergers and Acquisitions team. Rathsam comes to Trucordia after nearly five years at Arthur J. Gallagher, where she led M&A sourcing and deal execution across U.S., Western Canada, Australia, and New Zealand.
More news about: Trucordia
Apr 23, 2026, 08:00 ET Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery
context, expanding our wide body of existing research on the patented mineral complex into the sports nutrition market with newly added benefits," said J. Randal Wexler, Vice President of R&D and General Counsel at FutureCeuticals. "These recovery benefits are a natural complement to our long history
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 08:00 ET Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery
context, expanding our wide body of existing research on the patented mineral complex into the sports nutrition market with newly added benefits," said J. Randal Wexler, Vice President of R&D and General Counsel at FutureCeuticals. "These recovery benefits are a natural complement to our long history
More news about: FutureCeuticals, Inc.
Apr 23, 2026, 08:00 ET PKF O'Connor Davies Rises to #8 in Vault's 2027 "Best Accounting Firms," Continuing Upward Momentum
Kevin J. Keane, Chief Executive Officer at PKF O'Connor Davies. "Our steadfast focus on culture, professional development and team member satisfaction continues
More news about: PKF, O'Connor Davies, LLP
Apr 23, 2026, 08:00 ET Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors
Repertoire team generated an optimized TCR bispecific immune medicine that harnesses the immune system against difficult-to-treat solid tumors," said Anthony J. Coyle, PhD, President, Research and Development at Repertoire. "The initiation of this trial marks an important milestone, as RPTR-1-201 is the first
More news about: Repertoire Immune Medicines
Apr 23, 2026, 06:55 ET Dover Reports First Quarter 2026 Results
performance measures are included as an exhibit herein.MANAGEMENT COMMENTARY:Dover's President and Chief Executive Officer, Richard J. Tobin, said, "We delivered a solid start to the year, with double-digit revenue growth driven by continued strength in our secular-growth-exposed end
More news about: Dover
Apr 23, 2026, 06:30 ET Lockheed Martin Reports First Quarter 2026 Financial Results
C-130J
More news about: Lockheed Martin
Apr 23, 2026, 03:00 ET SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress
United States | Dermatology | JAMA Dermatology | JAMA Network(3) Lomas, A., Leonardi-Bee, J. & Bath-Hextall, F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 166, 1069–1080 (2012).(4 ) Jiang, R., Fritz, M. & Que, S. K. T. Cutaneous
More news about: SkylineDx
Apr 23, 2026, 03:00 ET MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
Zinzani PL et al. Exp Hematol Oncol. 2024 Aug 22;13(1):87.Trotman J, et al. Intern Med J. 2019 Apr;49(4):422-433.Lymphoma Australia. Types of Lymphoma - Non-Hodgkin
More news about: Specialised Therapeutics
Apr 23, 2026, 02:34 ET DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS
[2] Ngoi NYL, Lee JY, Lim D, Thian YL, Lim YW, Chan JJ, Chay WY, Zhang Z, Gopinathan A, Lim SE, Low J, Ng J, Tong P, Lee YJ, Park J, Kim JW, Tan TZ, Zhu J, Tai BC, Choi CH, Kim BG, Tan DSP. Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a
More news about: National University Cancer Institute, Singapore (NCIS)